Recently, the U.S. Food and Drug Administration approved the first health device for diabetics that does not need a daily intervention by the user of the device. This is an extremely important step in the process of treating diabetes, as it is a disease that requires a high amount of self-care and discipline.
The technology that was approved is known as Abbott’s FreeStyle Libre Flash Glucose Monitoring System. This system continuously monitors the user’s blood glucose levels so as to make sure that their sugar intake is not too much. The usual method of this is by pricking their fingers or different parts of the body to take a blood sample, where the sample would then be slipped into a machine for diagnosis.
This new technology is far more of an advancement for those with the disease and would ultimately phase out the need to constantly prick one’s finger with a needle which can become not only inconvenient, but painful as well.
The users of the mHealth device have become more and more sophisticated with how they use it, and have been better able to self-treat their disease.
The company that created the device was quoted stating that “the FDA is always interested in new technologies that can help make the care of people living with chronic conditions, such as diabetes, easier and more manageable. This system allows people with diabetes to avoid the additional step of finger stick calibration, which can sometimes be painful, but still provides necessary information for treating their diabetes – with a wave of the mobile reader.
Technology like the one aforementioned had helped dot ensure that patients can have a better chance at living a normal life, and can help them to become pain free and better at monitoring their diseases.